Skip to main content
Log in

Des-gamma-carboxyprothrombin in hepatocellular carcinoma after vitamin K1 injection

  • Letters to the Editor
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Liebman H, Furie BC, Tong MJ, Blanchard RA, Lo KJ, Lee SD, Coleman MS, Furie B: Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N Engl J Med 310:1427–1431, 1984

    PubMed  Google Scholar 

  2. Soulier JP, Gozin D, Lefrere JJ: A new method to assay des-gamma-carboxyprothrombin results obtained in 75 cases of hepatocellular carcinoma. Gastroenterology 91:1258–1262, 1986

    PubMed  Google Scholar 

  3. Lefrere JJ, Gozin D, Soulier JP, Bettan L, Mavier P, Dhumeaux D, Guillaumont M, Leclercq M: Specificity of increased des-gamma-carboxyprothrombin in hepatocellular carcinoma after vitamin K1 injection. J Hepatol 5:27–29, 1987

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Buffet, C., Bismuth, E., Hagege, H. et al. Des-gamma-carboxyprothrombin in hepatocellular carcinoma after vitamin K1 injection. Digest Dis Sci 34, 963–964 (1989). https://doi.org/10.1007/BF01540290

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01540290

Keywords

Navigation